Press release
Psychosis Market Trends That Will Shape the Next Decade: Insights from Advancing Virtual Reality Therapy For Psychosis Treatment
Psychosis
How Large Will the Psychosis Market Size By 2025?
The overall scope of the psychosis market has experienced a robust expansion lately, projected to ascend from a valuation of $9.88 billion in 2024 to $10.46 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.8%. This upward trajectory observed in the past is largely associated with the rising incidence of various mental health disorders, a burgeoning demand for therapeutic solutions in mental wellness, the broad utilization of conventional antipsychotic medications, the escalating deployment of cognitive behavioral therapy techniques, and the pervasive influence of stressful global and economic environments.
How Big Is the Psychosis Market Size Expected to Grow by 2029?
The overall valuation for the psychosis sector is projected for considerable expansion over the coming years, reaching a substantial $13.02 billion by the year 2029, driven by a steady compounded annual growth rate of 5.6%. This anticipated upward trajectory is fueled by several key factors: the increasing incidence of stress and related contributory elements, the escalating weight of mental health issues stemming from shifts in modern living patterns, amplified governmental support and programs, greater acceptance and utilization of therapeutic approaches centered on mindfulness, and increased capital allocation toward investigating mental health and pioneering new treatment modalities. Furthermore, significant movements shaping this market include the rollout of groundbreaking pharmaceutical solutions, progress in the technology used for diagnosis, the emergence of new injectable pharmaceutical products, the integration of biological markers in care, and a heightened requirement for patient-specific medical approaches.
View the full report here:
https://www.thebusinessresearchcompany.com/report/psychosis-global-market-report
Which Key Market Drivers Powering Psychosis Market Expansion and Growth?
Anticipated expansion within the psychosis market is being fueled by the rising prevalence of mental health disorders, which encompass impairments affecting an individual's affect, cognition, conduct, and general psychological state. This surge in mental health issues stems from factors such as elevated stress, shifting lifestyles, detachment from social networks, financial duress, and inherited vulnerabilities. Therapies for psychosis aid those battling these conditions via prompt identification, clinical management, and tailored interventions, consequently boosting the utilization of both antipsychotic pharmaceuticals and various therapeutic approaches. Illustratively, data from the US organization National Alliance On Mental Illness indicated that in 2024, approximately 600,000 hospital admissions annually within the United States for those aged 18 to 44 were attributable to psychosis spectrum and mood disorders, directly establishing a strong correlation between the escalation of mental health struggles and the trajectory of market expansion for psychosis treatments.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21266&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Psychosis Market?
Leading entities within the psychosis sector are heavily invested in pioneering sophisticated virtual reality (VR) based psychological treatments, aiming to elevate patient recovery through highly engaging and bespoke mental wellness strategies. This form of VR psychological therapy functions by enveloping patients within meticulously crafted, digitally simulated settings, designed to mitigate suffering, boost mental acuity, and refine social competencies via structured guidance, presenting a secure yet potent methodology for controlling symptoms. To illustrate, in the spring of 2022, OxfordVR, a digital therapeutics firm based in the United States, introduced gameChangeVR, a program intended to lead patients through cognitive behavioral therapy (CBT) within immersive, virtual landscapes. This self-guided VR intervention, administered across a span of six weekly appointments, demonstrated considerable positive effects, especially for individuals grappling with acute psychological difficulties, resulting in marked enhancements in their feelings of suspicion and their general standard of living. This emerging technological application holds substantial promise for vastly expanding the availability of successful mental health support, serving as an answer to the scarcity of qualified practitioners and providing a deployable resolution for addressing the needs of an immense population suffering from serious mental health conditions.
What Are the Emerging Segments in the Psychosis Market?
The psychosismarket covered in this report is segmented -
1) By Product: Tablet; Capsule; Injection
2) By Disease Type: Schizophrenia; Bipolar Disorder; Unipolar Depression; Dementia; Other Disease Types
3) By Distribution Channel: Online; Offline
4) By End-User: Hospitals; Healthcare Clinics; Speciality Clinics; Other End-Users
Subsegments:
1) By Tablet: Antipsychotic Tablets; Mood Stabilizer Tablets
2) By Capsule: Antipsychotic Capsules; Antidepressant Capsules
3) By Injection: Long-acting Injectable Antipsychotics; Short-acting Injectable Antipsychotics
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21266&type=smp
Who Are the Global Leaders in the Psychosis Market?
Major companies operating in the psychosis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Biogen Idec, Dr. Reddy's Laboratories Ltd., Lundbeck A/S, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Neuron Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals S.p.A., Anavex Life Sciences, BioXcel Therapeutics
Which are the Top Profitable Regional Markets for the Psychosis Industry?
North America was the largest region in the psychosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21266
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psychosis Market Trends That Will Shape the Next Decade: Insights from Advancing Virtual Reality Therapy For Psychosis Treatment here
News-ID: 4280294 • Views: …
More Releases from The Business Research Company
Competitive Landscape: Key Market Leaders and Emerging Participants in the Ultra …
The demand for ultra pure water is on a sharp rise, driven by its critical role across multiple high-tech and industrial sectors. As industries continue to advance, ensuring the availability of water free from contaminants becomes increasingly vital. Let us explore the current market outlook, key players, emerging trends, and segment details shaping the ultra pure water market's future.
Expected Market Size and Growth Outlook for Ultra Pure Water
The ultra…
Future Perspectives: Key Trends Shaping the Styrene-Petrochemicals Market Up to …
The styrene-petrochemicals sector is positioned for steady expansion in the coming years, driven by diverse industrial demands and evolving market trends. Understanding the current landscape, key players, and emerging innovations sheds light on the future trajectory of this important chemical market.
Expected Growth and Market Size of the Styrene-Petrochemicals Industry
The styrene-petrochemicals market is projected to reach a value of $82.11 billion by 2029, growing at a compound annual growth rate…
Segmentation, Main Trends, and Competitive Overview of the Silicone Market
The silicone market is poised for significant expansion over the coming years, driven by various technological and environmental factors. This sector is rapidly evolving to meet the rising demand across multiple industries, fueled by innovations and sustainability trends. Let's explore the market's size, key players, growth drivers, emerging trends, and segmentation to understand the future outlook better.
Projected Expansion of the Silicone Market by 2029
The silicone market is expected to…
Competitive Landscape: Leading Companies and New Entrants in the Printing Inks M …
The printing inks market is on a steady upward path, driven by evolving technological innovations and growing demands from various industries. As the need for sustainable and efficient printing solutions increases, this sector is poised for significant expansion in the coming years. Below is a detailed overview of the market size, key players, trends, and segmentation shaping the future of printing inks.
Expected Market Size and Growth Prospects of the Printing…
More Releases for Psychosis
"Faces of Psychosis" Redefines Art and Memoir with Unflinching Vision
Image: https://www.abnewswire.com/upload/2025/09/0dee09b98e12efa62723aec52dbb43c5.jpg
Shoreline, WA - Jairus Beane's Faces of Psychosis has ignited critical acclaim as a genre-defying masterpiece that fuses memoir, avant-garde photography, and mental health advocacy. Released today, the groundbreaking work, featuring 92 unaltered hallucinatory images, such as the visceral "Horror Strip" (page 95) and the abstract "Cotton Picasso" (page 92), positions Beane alongside visionaries like Yayoi Kusama and Frida Kahlo in transforming psychological turmoil into transcendent art. Galleries from…
Parkinson's Disease Psychosis (PDP) Market reaching approximately USD 3.7 billio …
Parkinson's disease (PD) is a chronic neurodegenerative disorder marked by tremors, rigidity, and movement difficulties. Beyond motor symptoms, many patients also develop Parkinson's disease psychosis (PDP), a non-motor complication characterized by hallucinations and delusions. PDP affects nearly half of advanced PD patients, contributing significantly to morbidity, caregiver burden, and long-term care requirements.
Historically, PDP management has been challenging because many antipsychotics worsen motor symptoms by interfering with dopamine pathways. However, with…
Autoimmune Psychosis Market Expected to Reach USD 3.8 Billion by 2034
Autoimmune psychosis is an emerging neuropsychiatric condition in which immune system dysfunction causes psychotic symptoms resembling schizophrenia or other psychiatric disorders. Unlike primary psychotic illnesses, autoimmune psychosis often has identifiable biomarkers and may respond to immunotherapy rather than traditional antipsychotics.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71359
This distinction is reshaping psychiatry and neurology, highlighting the importance of early recognition, advanced diagnostics, and personalized treatment. As awareness spreads among…
Psychosis Market Detailed Industry Report Analysis 2025-2034
Introduction
Psychosis is a severe mental health condition characterized by impaired thoughts, perceptions, and emotions, often presenting in disorders such as schizophrenia, bipolar disorder, and drug-induced psychosis. It significantly affects quality of life and imposes a substantial socioeconomic burden worldwide.
Growing awareness of mental health, increasing prevalence of psychiatric conditions, and the expanding pipeline of innovative drugs and therapies are shaping the psychosis market's future. By leveraging novel treatment approaches such as…
Autoimmune Psychosis Market: Epidemiology, Therapies, Companies, DelveInsight | …
Autoimmune Psychosis emerging therapies, such as ENSPRYNG (satralizumab, RG6168), ART5803, and others, are expected to boost the Autoimmune Psychosis Market in the upcoming years.
DelveInsight has launched a new report on "Autoimmune Psychosis - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Autoimmune Psychosis, historical and forecasted epidemiology as well as the Autoimmune Psychosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and…
Parkinson's Disease Psychosis Pipeline Insight Report 2024 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Parkinson's disease Psychosis Pipeline constitutes 5+ key companies continuously working towards developing 5+ Parkinson's Disease Psychosis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Parkinson's Disease Psychosis pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any),…
